Manorama Industries Reports Strong FY26 Growth, Plans Major Expansion

Manorama Industries has announced a robust financial year 2026, with Profit After Tax (PAT) soaring 108.1% year-on-year to ₹233.22 crore. Revenue also saw significant growth, climbing 76.1% to ₹1,357.70 crore.

The company attributed its strong performance to an improved product mix and enhanced capacity utilization. Manorama Industries also declared a final dividend of ₹0.80 per share for FY26, rewarding shareholders.

Driving Future Growth with Strategic Capex

Looking ahead, Manorama Industries plans significant strategic capital expenditure of ₹460 crore over the next 2-3 years. This investment is designed to drive further expansion and diversification of its operations.

Key initiatives include enhancing operational capabilities with a planned 30% capacity boost in the Solvent Fractionation Plant 2 (SF 2) and developing a new processing plant in Burkina Faso. These moves aim to broaden market reach and strengthen supply chain control.

About Manorama Industries

Manorama Industries is a prominent player in India's specialty fats market, producing essential ingredients like Cocoa Butter Equivalents (CBE) for the confectionery industry. Previous investments in its Solvent Fractionation Plant 2 have already enhanced its processing capabilities, supporting its focus on vertical integration and global expansion.

Risks and Competitive Landscape

Forward-looking statements regarding future performance are subject to inherent risks and uncertainties. These could include potential government actions, economic developments, or industry-specific challenges that might affect actual results.

In the specialty fats and food ingredients sector, Manorama Industries competes with major players like Adani Wilmar Ltd. and Patanjali Foods Ltd., both of which have diversified edible oil and food processing businesses.

What to Watch

Investors will be closely monitoring the execution of the ₹460 crore strategic capex plan over the next 2-3 years. Progress on planned capacity enhancements for Solvent Fractionation Plant 1 (SF 1) and the development of the Burkina Faso facility will also be key indicators. Future revenue and profit growth trends, alongside management commentary on market outlook and new product development, will be important to track.